Phillips-Medisize, a Molex company, has been named as the winner of the 16th CPhI Pharma Award in the category of Drug Delivery Devices. Winners are recognized for their innovation and dedication to driving the pharmaceutical industry forward, and were announced during the awards ceremony on the opening night of CPhI Worldwide/InnoPack, held November 5-7, in Frankfurt, Germany. Phillips-Medisize specifically was honored for the company’s Connected Health Platform (CHP), which encompasses extensive information-sharing, analytics capabilities, robust cybersecurity and streamlined regulatory documentation to support pharmaceutical, medical device and diagnostics companies worldwide. “With a strong focus on quality, safety and more than a decade of experience in developing connected health solutions, we thank CPhI for acknowledging our contributions to the industry,” said Matt Jennings, CEO and President of Phillips-Medisize. “We’re always striving to help our global customers conquer the significant challenge of improving patient medication adherence and outcomes, contain healthcare costs and accelerate time to market for novel healthcare advancements.